Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Paying Attention with Play Attention | Main | Institute for Ethics and Emerging Technologies »

January 9, 2006

The Neurotech Industry Conference May 18th - A Must Attend Event

Email This Entry

Posted by Zack Lynch

If you have ever found the information I post on Brain Waves to be valuable, then I highly recommend that you attend a conference I have been planning: The Neurotechnology Industry Investment and Business Conference to be held on May 18th in San Francisco. The NeuroInsights team has looked across the globe to bring you 40 of the leading doers and thinkers from across the neurotech landscape.

399_Neurotech_Conference_copy.jpg

Investors, executives, entrepreneurs, and leading researchers involved in the development of new drugs, devices and diagnostics for the brain and nervous system are coming together to shape the future of their organization and the neurotechnology industry.

This market defining one-day conference features keynotes on state of the neurotech industry, cutting edge company presentations, and panel discussions on a comprehensive selection of neurotech topics of interest to biotech, medtech, and IT investors and executives.

• Learn who investing in neurotech and why
• What start ups are getting funded
• How are public neurotech companies stocks performing
• Learn in what markets devices are competing with pharma
• Hear how brain imaging and informatics impacting drug development
• Learn what venture and strategic investors are looking for
• Discover emerging technologies and companies
• Find out about new licensing and partnering opportunities
• Learn about translational research & funding opportunities

Hear about next generation treatments for Alzheimer’s, addiction, anxiety, depression, epilepsy, hearing loss, insomnia, multiple sclerosis, pain, Parkinson’s, stroke, schizophrenia, stroke, vision loss and other brain-related illnesses.

Over the next few weeks I'll be posting session descriptions, speakers and other important information as it relates to the conference. If you intend on joining us, you can see the agenda by clicking here. I also recommend registering sooner rather than later to take advantage of our early-bird price.

Comments (0) + TrackBacks (0) | Category: Neurotech Industry


POST A COMMENT

Thanks for signing in, . Now you can comment. (sign out)

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)





Remember me?


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
NIO Unveils Top 10 Neuroscience Trends for 2009
NIO CEO Media Tour in NYC Gets Results
O Neurocaster
Manuscript Sent to Japan
2009 Stem Cell Trendsetters in Neurology and Psychiatry
Mental Health Parity Legislation Passes within Financial Package
Holy Neurofinancial Meltdown Bernanke
Interest in Neuropolicy Grows